
AI Biomedical R&D Company

On April 28, BIO KOREA 2026, the largest and most influential international event in Korea's bio-health industry, will grandly open at the Seoul COEX Convention Center, featuring a diverse range of activities including business matchmaking, brand exhibitions, professional conferences, and investment summits.GBB invites you to this grand event to explore cutting-edge biotech trends and advanced technologies, and to deeply connect with opportunities for expanding the Asia-Pacific pharmaceuticals industry.

▲BIO KOREA 2026
During the same period, Guolong Liang, co-founder and chairman of Great Bay Bio, will lead the business team to attend the industry seminar by invitation."Fast and Better: AI-Driven Next-Generation Cell Line Development via Site-Specific Integration" - A deep dive into GBB's core technology of site-specific integration + AI-driven intelligence, revolutionizing the entire process of developing next-generation stable and high-efficiency cell lines. This advancement supports faster and better global biopharmaceutical product development, accelerating progress toward engineering and commercialization. Experts and industry peers from home and abroad are welcome to attend for exchange and discussion.

▲Industry Seminar
Email: BD@greatbay-bio.com
Phone: 18926497707 (Same for WeChat)

